Les Meilleurs doctors pour le traitement de dysplasie développementale de la hanche (DDH) en Espagne - TOP-3 des médecins

Le Dr Aranda a obtenu son diplôme en médecine et chirurgie de l'Université de Málaga en 1983. Il s'est spécialisé en traumatologie et orthopédie au Département de traumatologie et d'orthopédie chirurgicale de l'Instituto Dexeus de Barcelone entre 1988 et 1993. sous la direction du Dr Villarrubias. .

Tout au long de sa pratique médicale, le Dr Aranda a travaillé dans les principaux hôpitaux d'Espagne, a participé au soutien médical des Jeux olympiques de Barcelone de 1992 et a été traumatologue à la Fédération espagnole de motocyclisme lors des championnats d'Europe et du monde entre 1982 et 1992.

Le Dr Aranda concentre actuellement sa pratique médicale sur le traitement des pathologies de la hanche et du pied à l'hôpital Quironsalud Marbella et est traumatologue à la Sociedad Sportclinic Marbella, membre de la Société espagnole de chirurgie de la hanche Secca.

Professional experience

• 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
• 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
• Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

Education and qualifications

• 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
• Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

Scientific research and clinical trials

1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

Learning and Teaching

• 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

Specialization and innovation

• Knee replacement : Using the latest generation navigation systems, Rapid Recovery and ERAS protocols for accelerated recovery.
• Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
• Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
• Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

Recognition and achievements

• 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
• Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

Membership in professional organizations

• International Member of the American Academy of Orthopaedic Surgeons .
• Member of the Spanish Association of Arthroscopy .

The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation systems and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.